Outsourcing made easy with a one-stop solution to early phase drug development.
We are an integrated drug development solution company, offering pharmaceutical and biotechnology companies a proven, flexible approach that removes the need for multiple service providers during the early stages of drug development. Whether for one study or an end-to-end program, we help you reach critical decision-making milestones sooner by improving speed and ease from lead candidate selection to clinical proof of concept, and beyond. When partnering with Altasciences, you can experience up to 40% in time savings thanks to our integrated, one-stop solution offering.
We strive to create a true partnership with our clients, our partners, and our colleagues that enables a mutually supporting relationship built on a combination of excellent science and solid communication.
Helping sponsors get better drugs to the people who need them, faster, for over 25 years.
Our full-service offering is always tailored to your specific research needs:
- Preclinical research
- Clinical pharmacology
- Drug formulation
- Manufacturing and analytical services
- Bioanalysis
- Program management
- Medical writing
- Biostatics
- Data management
- And so much more!
Location: United States, Pennsylvania, Scott
Member count: 1001-5000
Founded date: 1992
Investors 1
Date | Name | Website |
- | Signet Hea... | signetheal... |
Mentions in press and media 25
Date | Title | Description | Category | Author | Source |
17.01.2022 | Altascienc... | LAVAL, Quebec--(BUSINESS WIRE)... | - | - | signetheal... |
07.01.2022 | Fujifilm... | New year, same Fujifilm Dios... | - | Josh Sulli... | endpts.com... |
06.01.2022 | Pfizer an... | Throughout the past two years,... | - | Zachary Br... | endpts.com... |
06.01.2022 | John Marag... | On his way out of Alnylam, o... | - | Paul Schlo... | endpts.com... |
06.01.2022 | A year af... | Altasciences CEO Chris Perki... | - | Josh Sulli... | endpts.com... |
06.01.2022 | Sosei and... | Sosei Heptares is teaming u... | - | Paul Schlo... | endpts.com... |
06.01.2022 | Pfizer an... | Eli Lilly is beefing up its fl... | - | Zachary Br... | endpts.com... |
06.01.2022 | Pfizer an... | Alnylam was a few years ahead ... | - | Zachary Br... | endpts.com... |
06.01.2022 | Novo Hold... | Roger Perlmutter hasn’t wasted... | - | Josh Sulli... | endpts.com... |
06.01.2022 | Foresite'... | A Foresite-incubated biote... | Financing | Max Gelman | endpts.com... |
Show more